Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice

MLA

Amparo Martínez-Pérez, et al. “Immunization with Nanovaccines Containing Mutated K-Ras Peptides and Imiquimod Aggravates Heterotopic Pancreatic Cancer Induced in Mice.” Frontiers in Immunology, vol. 14, Apr. 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1153724.

APA

Amparo Martínez-Pérez, Lara Diego-González, Manuel Vilanova, Alexandra Correia, Rosana Simón-Vázquez, & África González-Fernández. (2023). Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1153724

Chicago

Amparo Martínez-Pérez, Lara Diego-González, Manuel Vilanova, Alexandra Correia, Rosana Simón-Vázquez, and África González-Fernández. 2023. “Immunization with Nanovaccines Containing Mutated K-Ras Peptides and Imiquimod Aggravates Heterotopic Pancreatic Cancer Induced in Mice.” Frontiers in Immunology 14 (April). doi:10.3389/fimmu.2023.1153724.